Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Glutamine for Intestinal Permeability in ICU
NCT03113240Phase 3Completed
- Sponsor
- Shahid Beheshti University
- Start
- Apr 2017
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in critical illness, increased intestinal permeability, sponsored by Shahid Beheshti University. Started Apr 2017; status: completed.
02
Drugs
glutamine
03
Conditions
critical illnessincreased intestinal permeability
Beyond the preview
Go deeper on NCT03113240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113240.